Hyundai Bioscience Co., Ltd. - Current Ratio
048410.KQ
Price:
$6650
Market Cap:
$641.75B
Hyundai Bioscience Co., Ltd. is a biotechnology firm dedicated to creating and commercializing bio-fusion technologies that enable the precise delivery of active compounds throughout the human anatomy. The company offers Vitabrid C12, a novel vitamin C product engineered to provide active vitamin C directly to the skin. Additionally, it is advancing organic-inorganic hybrid technology, which functions as a sophisticated drug delivery system. This system integrates bio-friendly minerals to ensure the targeted and efficient transport of active substances to specific sites, a capability also leveraged in its anticancer drug carrier innovations. The enterprise was established in 2000 and is head...[Read more]
Industry
Biotechnology
IPO Date
2002-08-28
Stock Exchange
KOE
Ticker
048410.KQ
PE Ratio
[-29.41]
ROE
[-24.26%]
Current Ratio
[2.36]
Dividend Yield
[0%]
Enterprise Value
[647.46B]
Dividend History
The Current Ratio as of August 2026 (TTM) for Hyundai Bioscience Co., Ltd. (048410.KQ) is 2.36
According to Hyundai Bioscience Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.36. This represents a change of -29.52% compared to the average of 3.35 of the last 4 quarters.
Hyundai Bioscience Co., Ltd. (048410.KQ) Historical Current Ratio (quarterly & annually)
How has 048410.KQ Current Ratio performed in the past?
The mean historical Current Ratio of Hyundai Bioscience Co., Ltd. over the last ten years is 2.26. The current 2.36 Current Ratio has changed 10.38% with respect to the historical average. Over the past ten years (40 quarters), 048410.KQ's Current Ratio was at its highest in in the June 2025 quarter at 8.38. The Current Ratio was at its lowest in in the December 2024 quarter at 0.25.
Average
2.26
Median
2.22
Minimum
0.25
Maximum
4.37
Hyundai Bioscience Co., Ltd. (048410.KQ) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Hyundai Bioscience Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 809.57%
Maximum Annual Current Ratio = 4.37
Minimum Annual Increase = -88.65%
Minimum Annual Current Ratio = 0.25
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.25 | 809.57% |
| 2024 | 0.25 | -88.65% |
| 2023 | 2.18 | -18.26% |
| 2022 | 2.67 | 32.25% |
| 2021 | 2.02 | -53.81% |
| 2020 | 4.37 | 83.24% |
| 2019 | 2.39 | -23.56% |
| 2018 | 3.12 | 58.59% |
| 2017 | 1.97 | 45.72% |
| 2016 | 1.35 | -61.58% |
Hyundai Bioscience Co., Ltd. (048410.KQ) Average Current Ratio
How has 048410.KQ Current Ratio performed in the past?
The current Current Ratio of Hyundai Bioscience Co., Ltd. (048410.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.56
5-year avg
1.87
10-year avg
2.26
Hyundai Bioscience Co., Ltd. (048410.KQ) Current Ratio vs. Peers
How is 048410.KQ’s Current Ratio compared to its peers?
Hyundai Bioscience Co., Ltd.’s Current Ratio is greater than Komipharm International Co., Ltd. (1.31), greater than i-SENS, Inc. (1.76), less than Humedix Co., Ltd. (7.30), greater than BINEX Co., Ltd. (1.33), greater than Huons Global Co., Ltd. (1.65), less than Proteina Co., Ltd. (0), greater than JW Pharmaceutical Corporation (1.56), greater than Dentium Co. Ltd. (1.45), less than Genomictree Inc. (60.85), greater than JW Pharmaceutical Corporation (1.56),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.31 | $666.33B | |
| 1.76 | $501.28B | |
| 7.30 | $278.67B | |
| 1.33 | $212.42B | |
| 1.65 | $276.47B | |
| 0 | $401.48B | |
| 1.56 | $400.46B | |
| 1.45 | $313.48B | |
| 60.85 | $296.28B | |
| 1.56 | $609.67B |
Build a custom stock screener for Hyundai Bioscience Co., Ltd. (048410.KQ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hyundai Bioscience Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hyundai Bioscience Co., Ltd. (048410.KQ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hyundai Bioscience Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Hyundai Bioscience Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Hyundai Bioscience Co., Ltd. (048410.KQ)?
What is the highest Current Ratio for Hyundai Bioscience Co., Ltd. (048410.KQ)?
What is the 3-year average Current Ratio for Hyundai Bioscience Co., Ltd. (048410.KQ)?
What is the 5-year average Current Ratio for Hyundai Bioscience Co., Ltd. (048410.KQ)?
How does the current Current Ratio for Hyundai Bioscience Co., Ltd. (048410.KQ) compare to its historical average?